ZYXI News and Press, Zynex Inc. From 09/01/22

Zynex Medical to Participate in H.C. Wainwright Annual Global Investment Conference PR Newswire ENGLEWOOD, Colo. , Sept. 1, 2022 /PRNewswire/ -- Zynex, Inc . (Nasdaq: ZYXI), an innovative medical technology company specializing in the manufacture and...

After posting the worst first half of any year since 1970 (1), the stock market has come roaring back to life in Q3, with technology and risk bets leading the way following Fed Chair Jerome Powell’s signal at the July FOMC meeting of a possible shift in policy bearing. (2) The Fed beli...

Zynex Announces First Enrollments in Apheresis Donation Clinical Trial with Second Generation Fluid Monitoring System PR Newswire ENGLEWOOD, Colo. , Aug. 15, 2022 /PRNewswire/ -- Zynex, Inc . (Nasdaq: ZYXI), an innovative medical technology compa...

Zynex Recognized in Top 100 Healthcare Technology Companies of 2022 PR Newswire ENGLEWOOD, Colo. , Aug. 8, 2022 /PRNewswire/ -- Zynex, Inc . (Nasdaq: ZYXI) an innovative medical technology company specializing in the manufacture and sale of non-i...

Zynex Ranked in Top 50 Public Companies in Colorado PR Newswire ENGLEWOOD, Colo. , Aug. 3, 2022 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devi...

Zynex beat analysts' estimates despite the recession. Zynex is committed to bringing value to its shareholders with a new share buyback round. The company reaffirmed the guidance without considering the sale of CM-1600. Quarterly results in pills Zynex, Inc. ( ZYXI...

Two new Breakout Stocks for Week 31 with better than 10% short-term upside potential and a Dow 30 Pick. Average cumulative returns declined to +90.9% YTD. This week, one pick FXLV wiped out the weekly portfolio gains with their CEO termination and lowered revenue guidance ahead of Aug...

Zynex ( NASDAQ: ZYXI ) stock rose ~12% on July 29 after Q2 results beat analysts' estimates and the company reaffirmed its FY22 revenue outlook a day ago. The Englewood, Colo.-based medical device maker's Q2 revenue grew +18.49% Y/Y to $36.76M. "Our reps...

Zynex, Inc. (ZYXI) Q2 2022 Results Conference Call July 28, 2022 04:15 PM ET Company Participants Louisa Smith - Investor Relations-Gilmartin Group Thomas Sandgaard - Chairman, President and Chief Executive Officer Dan Moorhead - Chief Financial Officer Anna ...

Zynex press release ( NASDAQ: ZYXI ): Q2 GAAP EPS of $0.08 beats by $0.01 . Revenue of $36.76M (+18.6% Y/Y) beats by $0.46M . Zynex is reaffirming its full year 2022 revenue estimates in the range of $150-$170 million and Adjusted EBITDA between $25-$35 million...